APOE and metabolic dysfunction-associated steatotic liver disease: In our previous studies, deficiency of proinflammatory microRNA-155 (miR155) in atherogenic apolipoprotein E knock-out (ApoE KO, or ApoE-/-) mice results in the establishment of the first metabolically healthy obesity (MHO) mouse model with decreased aortic atherosclerosis, increased obesity, white adipose tissue hypertrophy and non-alcoholic fatty liver disease but without insulin resistance (31).